Reappraising the role of immediate intervention following thrombolytic recanalization in acute myocardial infarction

American Journal of Cardiology

Volumn 86, Issue 4, 2000, Pages 400-405

  Grech, Ever D ^a   Sutton, Andrew G C ^a   Campbell, Philip G ^a   Ashton, Victoria J ^b   Price, Dallas J A ^a   Hall, James A ^a   De Belder, Mark A ^a  

^a Cardiothorac Div S Cleveland H   (United Kingdom)

^b TEESSIDE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; ROC CURVE; STREPTOKINASE; TREATMENT OUTCOME;

EID: 0034663522     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00954-1     Document Type: Article

References (19)

1. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
2. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.
3. A prospective trial of intravenous streptokinase in acute myocardial infarction. N Engl J Med. 314:1986;1465-1471.
4. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 . Lancet. 2:1988;349-360.
5. Effects of intravenous APSAC on mortality after acute myocardial infarction preliminary report of a placebo-controlled clinical trial . Lancet. 1:1988;545-549.
6. Serruys P.W., Simoons M.L., Suryapranata H., Vermeer F., Wijns W., van den Brand M., Bar F., Zwann C., Krauss X.H., Remme W.J. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 7:1986;729-742.
7. Erbel R., Pop T., Henrichs K.J., von Olshausen K., Schuster C.J., Rupprecht H.J., Steuernagel C., Meyer J. Percutaneous transluminal coronary angioplasty after thrombolytic therapy a prospective controlled randomised trial . J Am Coll Cardiol. 8:1986;485-495.
8. Topol E.J., Weiss J.L., Brinker J.A., Brin K.P., Gottlieb S.O., Becker L.C., Bulkley B.H., Chandra N., Flaherty J.T., Gerstenblith G., Gottlieb S.H., Guerci A.D., Ouyang P., Llewellyn A.P., Weisfeld M.L., Shapiro E.P. Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator importance of coronary angioplasty . J Am Coll Cardiol. 6:1985;426-433.
9. Serruys P.W., Wijns W., van den Brand M., Ribiero V., Fioretti P., Simoons M.L., Kooijmann C.J., Reiber J.H.C., Hugenholz P.G. Is transluminal coronary angioplasty mandatory after successful thrombolysis? Br Heart J. 50:1983;257-265.
10. Rogers W.J., Baim D.S., Gore J.M., Brown B.G., Roberts R., Williams D.O., Chesebro J.H., Babb J.D., Sheehan F.H., Wackers F.J.T., Zaret B.L., Robertson T.L., Passamani E.R., Ross R., Knatterud G.L., Braunwald E. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial. Circulation. 81:1990;1457-1476.
11. Simoons M.L., Arnold A.E., Betriu A., de Bono D.P., Col J., Dougherty F.C., von Essen R., Lambertz H., Lubsen J., Meier B. Thrombolysis with tissue plasminogen activator in acute myocardial infarction no additional benefit from immediate percutaneous coronary angioplasty . Lancet. 1:1988;197-203.
12. Topol E.J., Califf R.M., George B.S., Kereiakes D.J., Abbotsmith C.W., Candela R.J., Lee K.L., Pitt B., Stack R.S., O'Neill W.W. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 317:1987;581-588.
13. Stone G.W., Brodie B.R., Griffin J.J., Morice M.C., Costantini C., St. Goar F.G., Overlie P.A., Popma J.J., McDonnell J., Jones D., O'Neill W.W., Grines C.L. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction in-hospital and 30-day results of the PAMI stent pilot trial . J Am Coll Cardiol. 31:1998;23-30.
14. Lefkovits J., Ivanhoe R.J., Califf R.M., Bergelson B.A., Anderson K.M., Stoner G.L., Weisman H.F., Topol E.J. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 77:1996;1045-1051.
15. Stone G.W., O'Neill W.W., Jones D., Grines C.L. The central unifying concept of TIMI-3 flow after primary PTCA and thrombolytic therapy in acute myocardial infarction (abstr). Circulation. 92:(suppl I):1996;I515.
16. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
17. Vogt A., von Essen R., Tebbe U., Feuerer W., Appel K.F., Neuhaus K.L. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction retrospective analysis of four German multicenter studies . J Am Coll Cardiol. 21:1993;1391-1395.
18. Lincoff A.M., Topol E.J., Califf R.M., Sigmon K.N., Lee K.L., Ohman E.M., Rosenschein U., Ellis S.G. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Am J Cardiol. 75:1995;871-876.
19. Ohman E.M., Califf R.M., Topol E.J., Candela R., Abbottsmith C., Ellis S., Sigmon K.N., Kereiakes D., George B., Stack R. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation. 82:1990;781-791.